Skip to main content
Premium Trial:

Request an Annual Quote

Future Release of GenoLogics' Clarity LIMS to Support Illumina's HiSeqX Ten

Premium

GenoLogics said this week that the upcoming release of its Clarity Laboratory Information Management System will support next generation sequencing workflows and integrations for Illumina's HiSeqX Ten sequencer.

The company said that it is developing and testing new capabilities for the LIMS with researchers at the Garvan Institute of Medical Research in Sydney, Australia prior to a general release set for March 2014. In a statement, Michael Ball, GenoLogics' CEO described his firm's plans to support the HiSeqX Ten as "an obvious next step," noting that the company's software already supports other sequencers in Illumina's portfolio.

GenoLogics will provide more information about the new product at the Advances in Genome Biology & Technology meeting next month.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.